FindTrial
Sign In

Remazolam combined with esketamine for the prevention of delirium after pediatric tonsillectomy

Remazolam combined with esketamine for the prevention of delirium after pediatric tonsillectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100664
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium in children

Interventions

Remazolam group:Remimazolam is used in anesthesia.
Esketamine group:Esketamine is used in anesthesia.
Remazolam combined with Esketamine group:Remazolam and esketamine used in anesthesia

Sponsors

Ningbo University Affiliated Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Aged 3-12 years, ASA I-II, scheduled for tonsil and/or adenoidectomy surgery.

Exclusion criteria

Exclusion criteria: Cardiopulmonary diseases, renal insufficiency, mental illness, drug allergy, preoperative use of sedatives, postoperative need to be transferred to the ICU, low intelligence, overweight (BMI greater than 21.8), recent respiratory tract infections, etc.

Design outcomes

Primary

MeasureTime frame
Pediatric Anesthesia Emergence Delirium scale score PAED;FLACC scale score;—

Secondary

MeasureTime frame
PACU stay duration;—

Countries

China

Contacts

Public ContactYina Chen

Ningbo University Affiliated Women and Children's Hospital

271642314@qq.com+86 188 6786 9018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026